Literature DB >> 8938890

Aspergillomas of the sphenoid sinus: a series of 10 cases treated by endoscopic sinus surgery.

J M Klossek1, L Peloquin, P J Fourcroy, J C Ferrie, J P Fontanel.   

Abstract

We report our experience with 10 cases of sphenoidal aspergillomas treated by endoscopic sinus surgery (ESS). Chronic symptoms such as cough, post-nasal discharge, dysphonia and even facial pain can be encountered in the history. Computerised tomography and, occasionally, magnetic resonance imaging are of great help in the assessment of this disease, especially when extensive skull base involvement is present. The radiological presentation can vary from an heterogeneous to homogeneous opacity with or without bone lysis to a frank pseudotumoural appearance. Four diagnostic tools have been evaluated to confirm the diagnosis: histology, direct smear, fungal cultures, and serology for Aspergillus. ESS has been successfully carried out without morbidity in all cases. No recurrence of the disease is seen after a mean follow-up of 27 months.

Entities:  

Mesh:

Year:  1996        PMID: 8938890

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

1.  Sphenoid sinus fungus ball.

Authors:  Alexandre Karkas; Raed Rtail; Emile Reyt; Nasser Timi; Christian Adrien Righini
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-01       Impact factor: 2.503

2.  Endoscopic treatment of the isolated sphenoid sinus lesions.

Authors:  Paolo Castelnuovo; Fabio Pagella; Lucia Semino; Francesca De Bernardi; Giovanni Delù
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-02       Impact factor: 2.503

Review 3.  Fungus balls of the paranasal sinuses: a review.

Authors:  Pierre Grosjean; Rainer Weber
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-15       Impact factor: 3.236

4.  Clinical Characteristics of Sphenoid Sinus Fungal Ball Patients With Visual Disturbance.

Authors:  Jong Sei Kim; Byung Kil Kim; Sang Duk Hong; Hyung Jin Kim; Hyo Yeol Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-05-03       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.